Skip to main content

IMUX- Immunic, Inc.

Immunic, Inc. (IMUX) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO1.00M$14.74M-
CEO860.0K$12.68M-
CFO560.0K$8.26M-
Other330.0K$4.87M-
COO330.0K$4.87M-

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Jun 13, 2025Nash DuaneExecutive ChairmanBuy20,000$0.83$16,694.00+124.8%+5.9%-
Jun 5, 2025Tardio JasonPresident And COOBuy12,512$0.79$9,884.48New+4.1%+1552.2%
Jun 5, 2025Neermann Joerg67DirectorBuy100,000$0.77$76,700.00+37.0%+4.1%+1552.2%
Jun 4, 2025Vitt Daniel57CEO And DirectorBuy15,000$0.77$11,550.00+107.1%+3.1%+1761.9%
Jun 3, 2025Rudick Richard AlanDirectorBuy143,075$0.70$100,023.73+163.9%+9.4%+1948.2%
Jun 3, 2025Whaley Glenn49Chief Financial OfficerBuy45,000$0.71$32,076.00+89.1%+9.4%+1948.2%
Nov 12, 2024Rudick Richard AlanDirectorBuy87,300$1.15$100,368.81New-16.5%-33.9%
Feb 26, 2024Vitt Daniel57President And CEOBuy14,000$1.31$18,333.00+3.7%-2.3%-10.2%
May 15, 2023Whaley Glenn49Chief Financial OfficerBuy5,000$1.75$8,750.00+24.4%+2.8%-27.3%
Dec 14, 2022Neermann Joerg67DirectorBuy82,000$1.25$102,642.00+115.5%+39.7%+15.9%
Page 1Next →